Yang, Xi-Ming <br/><br/>
NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO.  [electronic resource] 

 -  Journal of molecular and cellular cardiology  Mar 2004 
 - 411-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-2828 
<br/><br/><label>Standard No.: </label>10.1016/j.yjmcc.2003.12.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine A2 Receptor Antagonists<br/>Adenosine-5'-(N-ethylcarboxamide)--pharmacology<br/>Androstadienes--pharmacology<br/>Animals<br/>Bradykinin--pharmacology<br/>Caffeine--analogs & derivatives<br/>Enzyme Inhibitors--pharmacology<br/>Flavonoids--pharmacology<br/>In Vitro Techniques<br/>Infarction--metabolism<br/>Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>NG-Nitroarginine Methyl Ester--pharmacology<br/>Nitric Oxide--metabolism<br/>Nitric Oxide Synthase--metabolism<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Serine-Threonine Kinases--metabolism<br/>Proto-Oncogene Proteins--metabolism<br/>Proto-Oncogene Proteins c-akt<br/>Rabbits<br/>Receptors, Adenosine A2--metabolism<br/>Reperfusion<br/>Signal Transduction--drug effects<br/>Vasodilator Agents--pharmacology<br/>Wortmannin